TY - JOUR
T1 - Arrhythmogenic effect of sympathetic histamine in mouse hearts subjected to acute ischemia
AU - He, Gonghao
AU - Hu, Jing
AU - Li, Teng
AU - Ma, Xue
AU - Meng, Jingru
AU - Jia, Min
AU - Lu, Jun
AU - Ohtsu, Hiroshi
AU - Chen, Zhong
AU - Luo, Xiaoxing
N1 - Funding Information:
The authors want to thank Xiang Gao and his associates of Model Animal Re search Center of Nanjing University for their kind provision of Wads c-kit mutant mice (mast cell–deficient mice). This work was supported by grants from the National Natural Science Foun dation of China (30770669 and 30800310) and the National Science Foundation for Post-doctoral Scientists of China (20090451521).
PY - 2012/1
Y1 - 2012/1
N2 - The role of histamine as a newly recognized sympathetic neurotransmitter has been presented previously, and its postsynaptic effects greatly depended on the activities of sympathetic nerves. Cardiac sympathetic nerves become overactivated under acute myocardial ischemic conditions and release neurotransmitters in large amounts, inducing ventricular arrhythmia. Therefore, it is proposed that cardiac sympathetic histamine, in addition to norepinephrine, may have a significant arrhythmogenic effect. To test this hypothesis, we observed the release of cardiac sympathetic histamine and associated ventricular arrhythmogenesis that was induced by acute ischemia in isolated mouse hearts. Mast cell-deficient mice (MCDM) and histidine decarboxylase knockout (HDC -/-) mice were used to exclude the potential involvement of mast cells. Electrical field stimulation and acute ischemia-reperfusion evoked chemical sympathectomy-sensitive histamine release from the hearts of both MCDM and wild-type (WT) mice but not from HDC -/- mice. The release of histamine from the hearts of MCDM and WT mice was associated with the development of acute ischemia-induced ventricular tachycardia and ventricular fibrillation. The incidence and duration of induced ventricular arrhythmias were found to decrease in the presence of the selective histamine H 2 receptor antagonist famotidine. Additionally, the released histamine facilitated the arrhythmogenic effect of simultaneously released norepinephrine. We conclude that, under acute ischemic conditions, cardiac sympathetic histamine released by overactive sympathetic nerve terminals plays a certain arrhythmogenic role via H 2 receptors. These findings provided novel insight into the pathophysiological roles of sympathetic histamine, which may be a new therapeutic target for acute ischemia-induced arrhythmias.
AB - The role of histamine as a newly recognized sympathetic neurotransmitter has been presented previously, and its postsynaptic effects greatly depended on the activities of sympathetic nerves. Cardiac sympathetic nerves become overactivated under acute myocardial ischemic conditions and release neurotransmitters in large amounts, inducing ventricular arrhythmia. Therefore, it is proposed that cardiac sympathetic histamine, in addition to norepinephrine, may have a significant arrhythmogenic effect. To test this hypothesis, we observed the release of cardiac sympathetic histamine and associated ventricular arrhythmogenesis that was induced by acute ischemia in isolated mouse hearts. Mast cell-deficient mice (MCDM) and histidine decarboxylase knockout (HDC -/-) mice were used to exclude the potential involvement of mast cells. Electrical field stimulation and acute ischemia-reperfusion evoked chemical sympathectomy-sensitive histamine release from the hearts of both MCDM and wild-type (WT) mice but not from HDC -/- mice. The release of histamine from the hearts of MCDM and WT mice was associated with the development of acute ischemia-induced ventricular tachycardia and ventricular fibrillation. The incidence and duration of induced ventricular arrhythmias were found to decrease in the presence of the selective histamine H 2 receptor antagonist famotidine. Additionally, the released histamine facilitated the arrhythmogenic effect of simultaneously released norepinephrine. We conclude that, under acute ischemic conditions, cardiac sympathetic histamine released by overactive sympathetic nerve terminals plays a certain arrhythmogenic role via H 2 receptors. These findings provided novel insight into the pathophysiological roles of sympathetic histamine, which may be a new therapeutic target for acute ischemia-induced arrhythmias.
UR - http://www.scopus.com/inward/record.url?scp=84863042846&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863042846&partnerID=8YFLogxK
U2 - 10.2119/molmed.2011.00225
DO - 10.2119/molmed.2011.00225
M3 - Article
C2 - 21989948
AN - SCOPUS:84863042846
VL - 18
SP - 1
EP - 9
JO - Molecular Medicine
JF - Molecular Medicine
SN - 1076-1551
IS - 1
ER -